Wednesday, June 11, 2008 9:51:14 AM
Chmn Laukien buys 50,000 of Bruker Corp. BRKR
SOURCE: Form 4
ISSUER: BRUKER CORP
SYMBOL: BRKR
FILER: LAUKIEN FRANK H
TITLE: Chairman of the Board
DATE TRANSACTION SHARES PRICE VALUE
6/9/08 Purchase 50,000 $11.60 $579,755
OWNERSHIP: 36,454,445 (Direct)
The Form 4 is filed with the Securities and Exchange Commission by insiders
to report transactions in their companies' shares. Open market purchases
and sales must be reported within two business days of the transaction.
SOURCE: Form 4
ISSUER: BRUKER CORP
SYMBOL: BRKR
FILER: LAUKIEN FRANK H
TITLE: Chairman of the Board
DATE TRANSACTION SHARES PRICE VALUE
6/9/08 Purchase 50,000 $11.60 $579,755
OWNERSHIP: 36,454,445 (Direct)
The Form 4 is filed with the Securities and Exchange Commission by insiders
to report transactions in their companies' shares. Open market purchases
and sales must be reported within two business days of the transaction.
Recent BRKR News
- Bruker Spatial Biology Showcases High Fidelity Spatial Data and Integrated Multi-platform Workflows for Unprecedented Multiomic Insights at AACR 2026 • Business Wire • 04/17/2026 01:00:00 PM
- Bruker Launches MyGenius PRO® High-Throughput Sample-to-Answer Molecular Diagnostics System at ESCMID 2026 • Business Wire • 04/17/2026 10:00:00 AM
- Bruker Expands Industry-Leading MALDI Biotyper® and IR Biotyper® Workflows for Microbial Identification and Outbreak Management • Business Wire • 04/17/2026 10:00:00 AM
- Bruker Unveils New NMR Products and Workflow Solutions at ENC 2026 • Business Wire • 04/13/2026 11:00:00 AM
- Bruker Invests in Photothermal AFM-IR to Advance Semiconductor Research • Business Wire • 04/07/2026 11:00:00 AM
- Bruker Announces Appointment of Thierry Bernard to its Board of Directors • Business Wire • 04/01/2026 11:00:00 AM
- PreOmics GmbH and Biognosys AG Prevail in U.S. Patent Challenge • Business Wire • 03/31/2026 05:07:00 PM
- Bruker Accelerates the Future of Diagnostic and Prognostic Spatial Proteomics with the Launch of CellScape XR • Business Wire • 02/25/2026 12:00:00 PM
- Bruker Expands Collaboration with Noetik to Advance Tissue Foundational Models for Translational and Therapeutic Applications • Business Wire • 02/24/2026 12:00:00 PM
- Bruker Advances Functional Proteomics 2.0 with timsOmniTM Mass Spectrometry Proteoform Analysis for Deeper Insights into Disease Biology • Business Wire • 02/23/2026 12:00:00 PM
- Bruker Announces Major Advancements at AGBT to Enable Complete High-Fidelity Spatial Biology Across the Biological Spectrum • Business Wire • 02/23/2026 12:00:00 PM
- Bruker Reports Fourth Quarter and Full Year 2025 Financial Results • Business Wire • 02/12/2026 12:00:00 PM
- Chemspeed and SciY Announce Self‑Driving Laboratory Platform Integrating Automation, Analytics and AI Orchestration • Business Wire • 02/09/2026 12:00:00 PM
- Bruker Introduces iNTApharma™, a Label‑Free Platform for Nanoparticle Characterization in mRNA Drug and Gene Therapy Development and QC • Business Wire • 02/09/2026 12:00:00 PM
- Bruker Announces Quarterly Preferred Stock Dividend • Business Wire • 02/05/2026 09:05:00 PM
- Bruker Announces Date and Time of Fourth Quarter 2025 Earnings Release and Webcast • Business Wire • 02/05/2026 01:00:00 PM
- Bruker Announces $500 Million in Multi-Year Orders from Two Global Healthcare Companies for Supply of High-Performance Superconductors for MRI • Business Wire • 01/09/2026 12:00:00 PM
- Bruker Consolidates Ownership of TOFWERK in Expansion of Mass Spectrometry Portfolio into New Applied Markets • Business Wire • 01/08/2026 12:00:00 PM
- Bruker Corporation to Present at the J.P. Morgan Healthcare Conference • Business Wire • 01/07/2026 09:01:00 PM
- RI Research Instruments Announces Major Orders for Enabling Technology for the Gamma-Ray Source of the Extreme Light Infrastructure (ELI) • Business Wire • 12/22/2025 03:04:00 PM
- Bruker Announces Orders for High-Performance Magnetic Resonance Systems for Materials and Life-Science Research from Leading European Institutions • Business Wire • 12/10/2025 12:00:00 PM
- Bruker Announces the Addition of Diagnostics Industry Leader Jack Phillips to its Board of Directors as of January 2026 • Business Wire • 12/08/2025 01:00:00 PM
- Bruker Announces Quarterly Common Stock Dividend and Preferred Stock Dividend • Business Wire • 11/04/2025 09:01:00 PM
- Bruker Shares Dip 3% After Q3 Beat but Weaker Full-Year Outlook • IH Market News • 11/03/2025 02:36:20 PM
- Bruker Reports Third Quarter 2025 Financial Results • Business Wire • 11/03/2025 12:00:00 PM
